logo
Share SHARE
FONT-SIZE Plus   Neg

Covidien Gets FDA 510(k) Clearance For LigaSure Small Jaw, Open Sealer/divider

Covidien Ltd. (COV) said it secured 510(k) clearance from the U.S. Food and Drug Administration, or FDA, for the LigaSure curved, small jaw, open sealer/divider surgical instrument to be used in ear, nose and throat procedures.

According to the company, when working in confined surgical spaces, the proprietary LigaSure device addresses surgeons' needs by offering a low-temperature profile and minimal thermal spread to surrounding tissues. The LigaSure small jaw instrument provides an integrated cutting mechanism independent of sealing, leaving critical cutting decisions in the surgeon's hands.

In addition, LigaSure small jaw instrument's multifunctional design provides for blunt dissection and an enhanced experience for the surgeon, especially in confined surgical spaces. LigaSure technology, powered by the ForceTriad energy platform, gives surgeons a continuous output of energy, monitoring the tissue and making real-time adjustments 3,333 times/second to seal vessel walls.

Covidien noted that the new clearance, for the device's use in head and neck procedures, will allow for additional uses such as thyroidectomies, parotidectomies and additional open ENT procedures.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Japanese messaging service Line Corp. announced its decision to delay the setting of a price range for its initial public offering by one day, until Tuesday, citing the chaos caused by Brexit in global markets. Line was actually planning to announce the IPO price range on Monday, June 27, and the... Fujifilm launched a new version to its tiny instant printer line up. The new upgraded version, Instax Share SP-2, can be used to print photographs from smartphones in a faster pace. China Resources Pharmaceutical Group Ltd. has filed for an initial public offering in Hong Kong stock exchange, which could turn out to be the biggest IPO of drug company this year in Asia. China Resources Pharmaceutical Group aims to raise $1 billion through the IPO. Another Chinese company, Simcere...
comments powered by Disqus
Follow RTT